Much evidence indicates that ribosomal RNA in animal cells is first synthesized as a 45 S precursor which is cleaved to form a 32 S molecule and a molecule of 18 S rRNA. The 32 S molecule is subsequently converted to 28 S rRNA. From this model it follows that the two classes of rRNA should be produced in equimolar amounts. When newly synthesized RNA in growing human lymphocytes was labeled with Urd-3H, the ratio of radioactive 18 S:32-28 S rRNA was consistent with equimolar production of the two rRNA classes, as expected. However, nongrowing lymphocytes showed an apparent deficiency of new 18 S rRNA relative to the amount of 32-28 S rRNA produced. The deficiency was found to be the result of temporary retention in the nucleus of newly synthesized 32 S and 28 S rRNA which had no counterpart 18 S molecules. The extent of the 18 S deficiency was estimated from methylation studies, and was found to be about 50%. Thus, in resting lymphocytes, about half of the 18 S rRNA molecules originally synthesized are lost, presumably through degradation, if the model for rRNA production outlined above is correct. The apparent wastage of 18 S rRNA was reduced or eliminated after the lymphocytes were stimulated to grow. It is proposed that the wastage of rRNA in resting lymphocytes is part of a control mechanism which regulates lymphocyte growth by limiting the accumulation of ribosomes.
No takes yet. Share an insight, caveat, or question.
Herbert L. Cooper (1969) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: